img

Global Hepatitis Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hepatitis Vaccine Market Research Report 2024

Hepatitis vaccine is a vaccine that prevents hepatitis
According to Mr Accuracy reports new survey, global Hepatitis Vaccine market is projected to reach US$ 2413.8 million in 2029, increasing from US$ 2114.5 million in 2022, with the CAGR of 1.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hepatitis Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hepatitis Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Sanofi
Sinovac
Zhejiang Pukang
IMBCA
ChangSheng
Segment by Type
Hepatitis A Vaccines
Hepatitis B Vaccines

Segment by Application


Children
Adult

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Hepatitis Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Hepatitis Vaccine Market Overview
1.1 Product Overview and Scope of Hepatitis Vaccine
1.2 Hepatitis Vaccine Segment by Type
1.2.1 Global Hepatitis Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Hepatitis A Vaccines
1.2.3 Hepatitis B Vaccines
1.3 Hepatitis Vaccine Segment by Application
1.3.1 Global Hepatitis Vaccine Market Value by Application: (2024-2034)
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hepatitis Vaccine Revenue 2018-2029
1.4.2 Global Hepatitis Vaccine Sales 2018-2029
1.4.3 Global Hepatitis Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hepatitis Vaccine Market Competition by Manufacturers
2.1 Global Hepatitis Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Hepatitis Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Hepatitis Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Hepatitis Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Hepatitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis Vaccine, Product Type & Application
2.7 Hepatitis Vaccine Market Competitive Situation and Trends
2.7.1 Hepatitis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis Vaccine Players Market Share by Revenue
2.7.3 Global Hepatitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis Vaccine Retrospective Market Scenario by Region
3.1 Global Hepatitis Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hepatitis Vaccine Global Hepatitis Vaccine Sales by Region: 2018-2029
3.2.1 Global Hepatitis Vaccine Sales by Region: 2018-2024
3.2.2 Global Hepatitis Vaccine Sales by Region: 2024-2029
3.3 Global Hepatitis Vaccine Global Hepatitis Vaccine Revenue by Region: 2018-2029
3.3.1 Global Hepatitis Vaccine Revenue by Region: 2018-2024
3.3.2 Global Hepatitis Vaccine Revenue by Region: 2024-2029
3.4 North America Hepatitis Vaccine Market Facts & Figures by Country
3.4.1 North America Hepatitis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hepatitis Vaccine Sales by Country (2018-2029)
3.4.3 North America Hepatitis Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Hepatitis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hepatitis Vaccine Sales by Country (2018-2029)
3.5.3 Europe Hepatitis Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hepatitis Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Hepatitis Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Hepatitis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hepatitis Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Hepatitis Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hepatitis Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hepatitis Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis Vaccine Sales by Type (2018-2029)
4.1.1 Global Hepatitis Vaccine Sales by Type (2018-2024)
4.1.2 Global Hepatitis Vaccine Sales by Type (2024-2029)
4.1.3 Global Hepatitis Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Hepatitis Vaccine Revenue by Type (2018-2029)
4.2.1 Global Hepatitis Vaccine Revenue by Type (2018-2024)
4.2.2 Global Hepatitis Vaccine Revenue by Type (2024-2029)
4.2.3 Global Hepatitis Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Hepatitis Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hepatitis Vaccine Sales by Application (2018-2029)
5.1.1 Global Hepatitis Vaccine Sales by Application (2018-2024)
5.1.2 Global Hepatitis Vaccine Sales by Application (2024-2029)
5.1.3 Global Hepatitis Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Hepatitis Vaccine Revenue by Application (2018-2029)
5.2.1 Global Hepatitis Vaccine Revenue by Application (2018-2024)
5.2.2 Global Hepatitis Vaccine Revenue by Application (2024-2029)
5.2.3 Global Hepatitis Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Hepatitis Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 GSK Hepatitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 NCPC Hepatitis Vaccine Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Merck Hepatitis Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Corporation Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Bio Kangtai Hepatitis Vaccine Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Corporation Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Dynavax Hepatitis Vaccine Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Hissen Hepatitis Vaccine Product Portfolio
6.6.5 Hissen Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 KM Biologics Hepatitis Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 LG Life Sciences Hepatitis Vaccine Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Serum Institute Hepatitis Vaccine Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sanofi Hepatitis Vaccine Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Sinovac
6.11.1 Sinovac Corporation Information
6.11.2 Sinovac Hepatitis Vaccine Description and Business Overview
6.11.3 Sinovac Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Sinovac Hepatitis Vaccine Product Portfolio
6.11.5 Sinovac Recent Developments/Updates
6.12 Zhejiang Pukang
6.12.1 Zhejiang Pukang Corporation Information
6.12.2 Zhejiang Pukang Hepatitis Vaccine Description and Business Overview
6.12.3 Zhejiang Pukang Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Zhejiang Pukang Hepatitis Vaccine Product Portfolio
6.12.5 Zhejiang Pukang Recent Developments/Updates
6.13 IMBCA
6.13.1 IMBCA Corporation Information
6.13.2 IMBCA Hepatitis Vaccine Description and Business Overview
6.13.3 IMBCA Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 IMBCA Hepatitis Vaccine Product Portfolio
6.13.5 IMBCA Recent Developments/Updates
6.14 ChangSheng
6.14.1 ChangSheng Corporation Information
6.14.2 ChangSheng Hepatitis Vaccine Description and Business Overview
6.14.3 ChangSheng Hepatitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 ChangSheng Hepatitis Vaccine Product Portfolio
6.14.5 ChangSheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis Vaccine Industry Chain Analysis
7.2 Hepatitis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis Vaccine Production Mode & Process
7.4 Hepatitis Vaccine Sales and Marketing
7.4.1 Hepatitis Vaccine Sales Channels
7.4.2 Hepatitis Vaccine Distributors
7.5 Hepatitis Vaccine Customers
8 Hepatitis Vaccine Market Dynamics
8.1 Hepatitis Vaccine Industry Trends
8.2 Hepatitis Vaccine Market Drivers
8.3 Hepatitis Vaccine Market Challenges
8.4 Hepatitis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Hepatitis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Hepatitis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Hepatitis Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Hepatitis Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Hepatitis Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Hepatitis Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Hepatitis Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Hepatitis Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Hepatitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Hepatitis Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Hepatitis Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Hepatitis Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Hepatitis Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Hepatitis Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Hepatitis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Hepatitis Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Hepatitis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Hepatitis Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Hepatitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Hepatitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Hepatitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Hepatitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Hepatitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Hepatitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Hepatitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Hepatitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Hepatitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Hepatitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Hepatitis Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Hepatitis Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Hepatitis Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Hepatitis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hepatitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Hepatitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Hepatitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Hepatitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Hepatitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hepatitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Hepatitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Hepatitis Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Hepatitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Hepatitis Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Hepatitis Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Hepatitis Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Hepatitis Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Hepatitis Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Hepatitis Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Hepatitis Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Hepatitis Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Hepatitis Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Hepatitis Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Hepatitis Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Hepatitis Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Hepatitis Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Hepatitis Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Hepatitis Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Hepatitis Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Hepatitis Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Hepatitis Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Hepatitis Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Hepatitis Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. GSK Hepatitis Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. NCPC Corporation Information
Table 76. NCPC Description and Business Overview
Table 77. NCPC Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. NCPC Hepatitis Vaccine Product
Table 79. NCPC Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Merck Hepatitis Vaccine Product
Table 84. Merck Recent Developments/Updates
Table 85. Bio Kangtai Corporation Information
Table 86. Bio Kangtai Description and Business Overview
Table 87. Bio Kangtai Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Bio Kangtai Hepatitis Vaccine Product
Table 89. Bio Kangtai Recent Developments/Updates
Table 90. Dynavax Corporation Information
Table 91. Dynavax Description and Business Overview
Table 92. Dynavax Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Dynavax Hepatitis Vaccine Product
Table 94. Dynavax Recent Developments/Updates
Table 95. Hissen Corporation Information
Table 96. Hissen Description and Business Overview
Table 97. Hissen Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Hissen Hepatitis Vaccine Product
Table 99. Hissen Recent Developments/Updates
Table 100. KM Biologics Corporation Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. KM Biologics Hepatitis Vaccine Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. LG Life Sciences Corporation Information
Table 106. LG Life Sciences Description and Business Overview
Table 107. LG Life Sciences Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. LG Life Sciences Hepatitis Vaccine Product
Table 109. LG Life Sciences Recent Developments/Updates
Table 110. Serum Institute Corporation Information
Table 111. Serum Institute Description and Business Overview
Table 112. Serum Institute Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Serum Institute Hepatitis Vaccine Product
Table 114. Serum Institute Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Sanofi Hepatitis Vaccine Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Sinovac Corporation Information
Table 121. Sinovac Description and Business Overview
Table 122. Sinovac Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sinovac Hepatitis Vaccine Product
Table 124. Sinovac Recent Developments/Updates
Table 125. Zhejiang Pukang Corporation Information
Table 126. Zhejiang Pukang Description and Business Overview
Table 127. Zhejiang Pukang Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Zhejiang Pukang Hepatitis Vaccine Product
Table 129. Zhejiang Pukang Recent Developments/Updates
Table 130. IMBCA Corporation Information
Table 131. IMBCA Description and Business Overview
Table 132. IMBCA Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. IMBCA Hepatitis Vaccine Product
Table 134. IMBCA Recent Developments/Updates
Table 135. ChangSheng Corporation Information
Table 136. ChangSheng Description and Business Overview
Table 137. ChangSheng Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. ChangSheng Hepatitis Vaccine Product
Table 139. ChangSheng Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Hepatitis Vaccine Distributors List
Table 143. Hepatitis Vaccine Customers List
Table 144. Hepatitis Vaccine Market Trends
Table 145. Hepatitis Vaccine Market Drivers
Table 146. Hepatitis Vaccine Market Challenges
Table 147. Hepatitis Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis Vaccine
Figure 2. Global Hepatitis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Hepatitis Vaccine Market Share by Type in 2022 & 2029
Figure 4. Hepatitis A Vaccines Product Picture
Figure 5. Hepatitis B Vaccines Product Picture
Figure 6. Global Hepatitis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Hepatitis Vaccine Market Share by Application in 2022 & 2029
Figure 8. Children
Figure 9. Adult
Figure 10. Global Hepatitis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Hepatitis Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Hepatitis Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Hepatitis Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Hepatitis Vaccine Report Years Considered
Figure 15. Hepatitis Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Hepatitis Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Hepatitis Vaccine Players: Market Share by Revenue in 2022
Figure 18. Hepatitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Hepatitis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Hepatitis Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Hepatitis Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Hepatitis Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Hepatitis Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Hepatitis Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Hepatitis Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Hepatitis Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Hepatitis Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hepatitis Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Hepatitis Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Hepatitis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Hepatitis Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Hepatitis Vaccine by Type (2018-2029)
Figure 54. Global Hepatitis Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Hepatitis Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Hepatitis Vaccine by Application (2018-2029)
Figure 57. Global Hepatitis Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Hepatitis Vaccine Value Chain
Figure 59. Hepatitis Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed